Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs121434592

Current Build 157

Released September 3, 2024

Organism
Homo sapiens
Position
chr14:104780214 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
C>A / C>G / C>T
Variation Type
SNV Single Nucleotide Variation
Frequency
T=0.000008 (1/118672, ExAC)
T=0.075 (59/788, PRJEB37584)
T=0.000 (0/476, ALFA)
Clinical Significance
Reported in ClinVar
Gene : Consequence
AKT1 : Stop Gained
Publications
26 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 476 C=1.000 T=0.000 1.0 0.0 0.0 N/A
European Sub 0 C=0 T=0 0 0 0 N/A
African Sub 424 C=1.000 T=0.000 1.0 0.0 0.0 N/A
African Others Sub 0 C=0 T=0 0 0 0 N/A
African American Sub 424 C=1.000 T=0.000 1.0 0.0 0.0 N/A
Asian Sub 0 C=0 T=0 0 0 0 N/A
East Asian Sub 0 C=0 T=0 0 0 0 N/A
Other Asian Sub 0 C=0 T=0 0 0 0 N/A
Latin American 1 Sub 0 C=0 T=0 0 0 0 N/A
Latin American 2 Sub 0 C=0 T=0 0 0 0 N/A
South Asian Sub 0 C=0 T=0 0 0 0 N/A
Other Sub 52 C=1.00 T=0.00 1.0 0.0 0.0 N/A


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
ExAC Global Study-wide 118672 C=0.999992 T=0.000008
ExAC Europe Sub 71544 C=0.99999 T=0.00001
ExAC Asian Sub 24836 C=1.00000 T=0.00000
ExAC American Sub 11390 C=1.00000 T=0.00000
ExAC African Sub 10022 C=1.00000 T=0.00000
ExAC Other Sub 880 C=1.000 T=0.000
CNV burdens in cranial meningiomas Global Study-wide 788 C=0.925 T=0.075
CNV burdens in cranial meningiomas CRM Sub 788 C=0.925 T=0.075
Allele Frequency Aggregator Total Global 476 C=1.000 T=0.000
Allele Frequency Aggregator African Sub 424 C=1.000 T=0.000
Allele Frequency Aggregator Other Sub 52 C=1.00 T=0.00
Allele Frequency Aggregator European Sub 0 C=0 T=0
Allele Frequency Aggregator Latin American 1 Sub 0 C=0 T=0
Allele Frequency Aggregator Latin American 2 Sub 0 C=0 T=0
Allele Frequency Aggregator South Asian Sub 0 C=0 T=0
Allele Frequency Aggregator Asian Sub 0 C=0 T=0
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 14 NC_000014.9:g.104780214C>A
GRCh38.p14 chr 14 NC_000014.9:g.104780214C>G
GRCh38.p14 chr 14 NC_000014.9:g.104780214C>T
GRCh37.p13 chr 14 NC_000014.8:g.105246551C>A
GRCh37.p13 chr 14 NC_000014.8:g.105246551C>G
GRCh37.p13 chr 14 NC_000014.8:g.105246551C>T
AKT1 RefSeqGene (LRG_721) NG_012188.1:g.20531G>T
AKT1 RefSeqGene (LRG_721) NG_012188.1:g.20531G>C
AKT1 RefSeqGene (LRG_721) NG_012188.1:g.20531G>A
Gene: AKT1, AKT serine/threonine kinase 1 (minus strand)
Molecule type Change Amino acid[Codon] SO Term
AKT1 transcript variant 1 NM_005163.2:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_005154.2:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant 1 NM_005163.2:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_005154.2:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant 1 NM_005163.2:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_005154.2:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant 3 NM_001014431.2:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001014431.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant 3 NM_001014431.2:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001014431.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant 3 NM_001014431.2:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001014431.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant 2 NM_001014432.2:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001014432.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant 2 NM_001014432.2:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001014432.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant 2 NM_001014432.2:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001014432.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant 4 NM_001382430.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369359.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant 4 NM_001382430.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369359.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant 4 NM_001382430.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369359.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant 7 NM_001382433.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369362.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant 7 NM_001382433.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369362.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant 7 NM_001382433.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369362.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant 6 NM_001382432.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369361.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant 6 NM_001382432.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369361.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant 6 NM_001382432.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369361.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant 5 NM_001382431.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369360.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant 5 NM_001382431.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369360.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant 5 NM_001382431.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase NP_001369360.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant X1 XM_047431069.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287025.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant X1 XM_047431069.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287025.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant X1 XM_047431069.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287025.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant X2 XM_047431070.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287026.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant X2 XM_047431070.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287026.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant X2 XM_047431070.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287026.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant X3 XM_047431071.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287027.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant X3 XM_047431071.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287027.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant X3 XM_047431071.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287027.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant X4 XM_047431072.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287028.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant X4 XM_047431072.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287028.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant X4 XM_047431072.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287028.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant X5 XM_047431073.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287029.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant X5 XM_047431073.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287029.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant X5 XM_047431073.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287029.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant X6 XM_047431074.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287030.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant X6 XM_047431074.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287030.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant X6 XM_047431074.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287030.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
AKT1 transcript variant X7 XM_047431075.1:c.49G>T E [GAG] > * [TAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287031.1:p.Glu17Ter E (Glu) > * (Ter) Stop Gained
AKT1 transcript variant X7 XM_047431075.1:c.49G>C E [GAG] > Q [CAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287031.1:p.Glu17Gln E (Glu) > Q (Gln) Missense Variant
AKT1 transcript variant X7 XM_047431075.1:c.49G>A E [GAG] > K [AAG] Coding Sequence Variant
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287031.1:p.Glu17Lys E (Glu) > K (Lys) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: T (allele ID: 29022 )
ClinVar Accession Disease Names Clinical Significance
RCV000015017.4 Breast adenocarcinoma Pathogenic
RCV000015018.4 Carcinoma of colon Pathogenic
RCV000015019.4 Ovarian neoplasm Pathogenic
RCV000031926.9 Proteus syndrome Pathogenic
RCV000419412.1 Prostate adenocarcinoma Likely-Pathogenic
RCV000421009.1 Thyroid tumor Likely-Pathogenic
RCV000421696.1 Bone osteosarcoma Likely-Pathogenic
RCV000421850.1 Small cell lung carcinoma Likely-Pathogenic
RCV000426386.1 Malignant melanoma of skin Likely-Pathogenic
RCV000427484.1 Gastric adenocarcinoma Likely-Pathogenic
RCV000429060.1 Neoplasm of the large intestine Pathogenic
RCV000430173.1 Breast neoplasm Pathogenic
RCV000431237.1 Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation Likely-Pathogenic
RCV000431723.1 Lung adenocarcinoma Likely-Pathogenic
RCV000434120.1 Tumor of meninges Likely-Pathogenic
RCV000436698.1 Non-small cell lung carcinoma Pathogenic
RCV000438154.1 Neoplasm of uterine cervix Likely-Pathogenic
RCV000439982.1 Squamous cell carcinoma of the head and neck Likely-Pathogenic
RCV000440828.1 Squamous cell lung carcinoma Likely-Pathogenic
RCV000443761.1 Transitional cell carcinoma of the bladder Likely-Pathogenic
RCV000444311.1 Hepatocellular carcinoma Likely-Pathogenic
RCV000445271.1 Prostate neoplasm Likely-Pathogenic
RCV000795313.6 Cowden syndrome 6 Pathogenic
RCV001813745.2 not provided Pathogenic
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement C= A G T
GRCh38.p14 chr 14 NC_000014.9:g.104780214= NC_000014.9:g.104780214C>A NC_000014.9:g.104780214C>G NC_000014.9:g.104780214C>T
GRCh37.p13 chr 14 NC_000014.8:g.105246551= NC_000014.8:g.105246551C>A NC_000014.8:g.105246551C>G NC_000014.8:g.105246551C>T
AKT1 RefSeqGene (LRG_721) NG_012188.1:g.20531= NG_012188.1:g.20531G>T NG_012188.1:g.20531G>C NG_012188.1:g.20531G>A
AKT1 transcript variant 1 NM_005163.2:c.49= NM_005163.2:c.49G>T NM_005163.2:c.49G>C NM_005163.2:c.49G>A
AKT1 transcript variant 2 NM_001014432.2:c.49= NM_001014432.2:c.49G>T NM_001014432.2:c.49G>C NM_001014432.2:c.49G>A
AKT1 transcript variant 2 NM_001014432.1:c.49= NM_001014432.1:c.49G>T NM_001014432.1:c.49G>C NM_001014432.1:c.49G>A
AKT1 transcript variant 3 NM_001014431.2:c.49= NM_001014431.2:c.49G>T NM_001014431.2:c.49G>C NM_001014431.2:c.49G>A
AKT1 transcript variant 3 NM_001014431.1:c.49= NM_001014431.1:c.49G>T NM_001014431.1:c.49G>C NM_001014431.1:c.49G>A
AKT1 transcript variant 7 NM_001382433.1:c.49= NM_001382433.1:c.49G>T NM_001382433.1:c.49G>C NM_001382433.1:c.49G>A
AKT1 transcript variant 6 NM_001382432.1:c.49= NM_001382432.1:c.49G>T NM_001382432.1:c.49G>C NM_001382432.1:c.49G>A
AKT1 transcript variant 4 NM_001382430.1:c.49= NM_001382430.1:c.49G>T NM_001382430.1:c.49G>C NM_001382430.1:c.49G>A
AKT1 transcript variant 5 NM_001382431.1:c.49= NM_001382431.1:c.49G>T NM_001382431.1:c.49G>C NM_001382431.1:c.49G>A
AKT1 transcript variant X6 XM_047431074.1:c.49= XM_047431074.1:c.49G>T XM_047431074.1:c.49G>C XM_047431074.1:c.49G>A
AKT1 transcript variant X1 XM_047431069.1:c.49= XM_047431069.1:c.49G>T XM_047431069.1:c.49G>C XM_047431069.1:c.49G>A
AKT1 transcript variant X5 XM_047431073.1:c.49= XM_047431073.1:c.49G>T XM_047431073.1:c.49G>C XM_047431073.1:c.49G>A
AKT1 transcript variant X2 XM_047431070.1:c.49= XM_047431070.1:c.49G>T XM_047431070.1:c.49G>C XM_047431070.1:c.49G>A
AKT1 transcript variant X3 XM_047431071.1:c.49= XM_047431071.1:c.49G>T XM_047431071.1:c.49G>C XM_047431071.1:c.49G>A
AKT1 transcript variant X4 XM_047431072.1:c.49= XM_047431072.1:c.49G>T XM_047431072.1:c.49G>C XM_047431072.1:c.49G>A
AKT1 transcript variant X7 XM_047431075.1:c.49= XM_047431075.1:c.49G>T XM_047431075.1:c.49G>C XM_047431075.1:c.49G>A
RAC-alpha serine/threonine-protein kinase NP_005154.2:p.Glu17= NP_005154.2:p.Glu17Ter NP_005154.2:p.Glu17Gln NP_005154.2:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase NP_001014432.1:p.Glu17= NP_001014432.1:p.Glu17Ter NP_001014432.1:p.Glu17Gln NP_001014432.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase NP_001014431.1:p.Glu17= NP_001014431.1:p.Glu17Ter NP_001014431.1:p.Glu17Gln NP_001014431.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase NP_001369362.1:p.Glu17= NP_001369362.1:p.Glu17Ter NP_001369362.1:p.Glu17Gln NP_001369362.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase NP_001369361.1:p.Glu17= NP_001369361.1:p.Glu17Ter NP_001369361.1:p.Glu17Gln NP_001369361.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase NP_001369359.1:p.Glu17= NP_001369359.1:p.Glu17Ter NP_001369359.1:p.Glu17Gln NP_001369359.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase NP_001369360.1:p.Glu17= NP_001369360.1:p.Glu17Ter NP_001369360.1:p.Glu17Gln NP_001369360.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287030.1:p.Glu17= XP_047287030.1:p.Glu17Ter XP_047287030.1:p.Glu17Gln XP_047287030.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287025.1:p.Glu17= XP_047287025.1:p.Glu17Ter XP_047287025.1:p.Glu17Gln XP_047287025.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287029.1:p.Glu17= XP_047287029.1:p.Glu17Ter XP_047287029.1:p.Glu17Gln XP_047287029.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287026.1:p.Glu17= XP_047287026.1:p.Glu17Ter XP_047287026.1:p.Glu17Gln XP_047287026.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287027.1:p.Glu17= XP_047287027.1:p.Glu17Ter XP_047287027.1:p.Glu17Gln XP_047287027.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287028.1:p.Glu17= XP_047287028.1:p.Glu17Ter XP_047287028.1:p.Glu17Gln XP_047287028.1:p.Glu17Lys
RAC-alpha serine/threonine-protein kinase isoform X1 XP_047287031.1:p.Glu17= XP_047287031.1:p.Glu17Ter XP_047287031.1:p.Glu17Gln XP_047287031.1:p.Glu17Lys
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

15 SubSNP, 3 Frequency, 24 ClinVar submissions
No Submitter Submission ID Date (Build)
1 OMIM-CURATED-RECORDS ss256302345 Aug 26, 2010 (132)
2 GENEREVIEWS ss539219251 Oct 10, 2012 (137)
3 EVA_EXAC ss1691656433 Apr 01, 2015 (144)
4 GNOMAD ss2740988744 Nov 08, 2017 (151)
5 ILLUMINA ss3625668160 Oct 12, 2018 (152)
6 ILLUMINA ss3725480206 Jul 13, 2019 (153)
7 EVA ss3984697828 Apr 26, 2021 (155)
8 YEGNASUBRAMANIAN_LAB ss6345868726 Nov 03, 2024 (157)
9 EVA ss6349885208 Nov 03, 2024 (157)
10 EVA ss6403987361 Nov 03, 2024 (157)
11 CPQ_GEN_INCA ss8236857257 Nov 03, 2024 (157)
12 CSS-BFX ss8442109898 Nov 03, 2024 (157)
13 EVA ss8936208207 Nov 03, 2024 (157)
14 EVA ss8981400719 Nov 03, 2024 (157)
15 EVA ss8981485921 Nov 03, 2024 (157)
16 ExAC NC_000014.8 - 105246551 Oct 12, 2018 (152)
17 CNV burdens in cranial meningiomas NC_000014.8 - 105246551 Apr 26, 2021 (155)
18 ALFA NC_000014.9 - 104780214 Nov 03, 2024 (157)
19 ClinVar RCV000015017.4 Oct 12, 2018 (152)
20 ClinVar RCV000015018.4 Oct 12, 2018 (152)
21 ClinVar RCV000015019.4 Oct 12, 2018 (152)
22 ClinVar RCV000031926.9 Nov 03, 2024 (157)
23 ClinVar RCV000419412.1 Oct 12, 2018 (152)
24 ClinVar RCV000421009.1 Oct 12, 2018 (152)
25 ClinVar RCV000421696.1 Oct 12, 2018 (152)
26 ClinVar RCV000421850.1 Oct 12, 2018 (152)
27 ClinVar RCV000426386.1 Oct 12, 2018 (152)
28 ClinVar RCV000427484.1 Oct 12, 2018 (152)
29 ClinVar RCV000429060.1 Oct 12, 2018 (152)
30 ClinVar RCV000430173.1 Oct 12, 2018 (152)
31 ClinVar RCV000431237.1 Oct 12, 2018 (152)
32 ClinVar RCV000431723.1 Oct 12, 2018 (152)
33 ClinVar RCV000434120.1 Oct 12, 2018 (152)
34 ClinVar RCV000436698.1 Oct 12, 2018 (152)
35 ClinVar RCV000438154.1 Oct 12, 2018 (152)
36 ClinVar RCV000439982.1 Oct 12, 2018 (152)
37 ClinVar RCV000440828.1 Oct 12, 2018 (152)
38 ClinVar RCV000443761.1 Oct 12, 2018 (152)
39 ClinVar RCV000444311.1 Oct 12, 2018 (152)
40 ClinVar RCV000445271.1 Oct 12, 2018 (152)
41 ClinVar RCV000795313.6 Nov 03, 2024 (157)
42 ClinVar RCV001813745.2 Nov 03, 2024 (157)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss8936208207 NC_000014.8:105246550:C:A NC_000014.9:104780213:C:A (self)
ss6349885208, ss8936208207 NC_000014.8:105246550:C:G NC_000014.9:104780213:C:G (self)
2015682, 247346, ss1691656433, ss2740988744, ss3625668160, ss3984697828, ss6345868726, ss6403987361, ss8236857257, ss8442109898, ss8936208207, ss8981400719, ss8981485921 NC_000014.8:105246550:C:T NC_000014.9:104780213:C:T (self)
RCV000015017.4, RCV000015018.4, RCV000015019.4, RCV000031926.9, RCV000419412.1, RCV000421009.1, RCV000421696.1, RCV000421850.1, RCV000426386.1, RCV000427484.1, RCV000429060.1, RCV000430173.1, RCV000431237.1, RCV000431723.1, RCV000434120.1, RCV000436698.1, RCV000438154.1, RCV000439982.1, RCV000440828.1, RCV000443761.1, RCV000444311.1, RCV000445271.1, RCV000795313.6, RCV001813745.2, 383682332, ss256302345, ss539219251, ss3725480206 NC_000014.9:104780213:C:T NC_000014.9:104780213:C:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

26 citations for rs121434592
PMID Title Author Year Journal
17611497 A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Carpten JD et al. 2007 Nature
18504432 AKT1(E17K) in human solid tumours. Bleeker FE et al. 2008 Oncogene
18611285 Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting. Do H et al. 2008 BMC research notes
19418217 Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma. Dunlap J et al. 2010 Breast cancer research and treatment
19487299 Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Ricarte-Filho JC et al. 2009 Cancer research
19853286 AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma. Cohen Y et al. 2010 Gynecologic oncology
20233444 A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes. Fumagalli D et al. 2010 BMC cancer
20453058 Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models. O'Brien C et al. 2010 Clinical cancer research
21464312 Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination. Jo H et al. 2011 Proceedings of the National Academy of Sciences of the United States of America
21512767 Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes. Boyault S et al. 2012 Breast cancer research and treatment
21793738 A mosaic activating mutation in AKT1 associated with the Proteus syndrome. Lindhurst MJ et al. 2011 The New England journal of medicine
22538770 Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers. Santarpia L et al. 2012 Breast cancer research and treatment
22610119 Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Barbieri CE et al. 2012 Nature genetics
22722201 The landscape of cancer genes and mutational processes in breast cancer. Stephens PJ et al. 2012 Nature
22722839 The mutational landscape of lethal castration-resistant prostate cancer. Grasso CS et al. 2012 Nature
22876373 Proteus Syndrome. Biesecker LG et al. 1993 GeneReviews(®)
22980975 Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Imielinski M et al. 2012 Cell
23237847 Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine. Yi KH et al. 2013 Oncotarget
23348505 Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Clark VE et al. 2013 Science (New York, N.Y.)
23700467 Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. Han SW et al. 2013 PloS one
23728071 A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features. Trigka EA et al. 2013 Oncology reports
23934607 Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis. Neumann J et al. 2013 Virchows Archiv
24190505 Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas. Joseph CG et al. 2014 Genes, chromosomes & cancer
24657128 Molecular profiling of small cell lung cancer in a Japanese cohort. Wakuda K et al. 2014 Lung cancer (Amsterdam, Netherlands)
25157968 Prospective enterprise-level molecular genotyping of a cohort of cancer patients. MacConaill LE et al. 2014 The Journal of molecular diagnostics
26619011 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Chang MT et al. 2016 Nature biotechnology
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post825+45319f0